The cell fate determinant Llgl1 influences HSC fitness and prognosis in AML

DSpace/Manakin Repository

The cell fate determinant Llgl1 influences HSC fitness and prognosis in AML

Citable link to this page

 

 
Title: The cell fate determinant Llgl1 influences HSC fitness and prognosis in AML
Author: Heidel, Florian H.; Bullinger, Lars; Arreba-Tutusaus, Patricia; Wang, Zhu; Gaebel, Julia; Hirt, Carsten; Niederwieser, Dietger; Lane, Steven W.; Döhner, Konstanze; Vasioukhin, Valera; Fischer, Thomas; Armstrong, Scott A.

Note: Order does not necessarily reflect citation order of authors.

Citation: Heidel, F. H., L. Bullinger, P. Arreba-Tutusaus, Z. Wang, J. Gaebel, C. Hirt, D. Niederwieser, et al. 2013. “The cell fate determinant Llgl1 influences HSC fitness and prognosis in AML.” The Journal of Experimental Medicine 210 (1): 15-22. doi:10.1084/jem.20120596. http://dx.doi.org/10.1084/jem.20120596.
Full Text & Related Files:
Abstract: A unique characteristic of hematopoietic stem cells (HSCs) is the ability to self-renew. Several genes and signaling pathways control the fine balance between self-renewal and differentiation in HSCs and potentially also in leukemia stem cells. Recently, studies have shed light on developmental molecules and evolutionarily conserved signals as regulators of stem cells in hematopoiesis and leukemia. In this study, we provide evidence that the cell fate determinant Llgl1 (lethal giant larvae homolog 1) plays an important role in regulation of HSCs. Loss of Llgl1 leads to an increase in HSC numbers that show increased repopulation capacity and competitive advantage after transplantation. This advantage increases upon serial transplantation or when stress is applied to HSCs. Llgl1−/− HSCs show increased cycling but neither exhaust nor induce leukemia in recipient mice. Llgl1 inactivation is associated with transcriptional repression of transcription factors such as KLF4 (Krüppel-like factor 4) and EGR1 (early-growth-response 1) that are known inhibitors of HSC self-renewal. Decreased Llgl1 expression in human acute myeloid leukemia (AML) cells is associated with inferior patient survival. Thus, inactivation of Llgl1 enhances HSC self-renewal and fitness and is associated with unfavorable outcome in human AML.
Published Version: doi:10.1084/jem.20120596
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549713/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:11717571
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters